Brief: Recro Pharma Awarded Development And Manufacturing Contract By National Institutes Of Health (Nih) To Support Novel Nasal Spray Analgesic
Oct 20 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO AWARDED DEVELOPMENT AND MANUFACTURING CONTRACT BY
NATIONAL
INSTITUTES OF HEALTH (NIH) TO SUPPORT NOVEL NASAL SPRAY
ANALGESIC
Source text for Eikon: ID:nGNX4zgGzV
Further company coverage: REPH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study